Access to insulin is not only an #affordability issue, it is also a #regulatory challenge.
Strong #regulatorysystems are key to improving access to safe and effective insulin & associated medical devices.
🎥 Presented by Cécile Macé
https://t.co/uokevEJSo2
A few months ago, #Hackccess & #Hackazihaz brought together innovators to tackle one urgent challenge: improving equity in #NCD care & access🔵
What started as ideas turned into real solutions. But what happened next?
🎥 Watch how these solutions have evolved since the hackathon
Want to publish your research but don’t know where to start?
Whether you are an #earlycareer researcher or looking to refine your #publication strategy, this #webinar will help you navigate the process with greater clarity and confidence.
🔗https://t.co/1RU2nSNhI5
100,000+ people in #Switzerland🇨🇭rely on insulin daily.
Yet global market shifts & supply vulnerabilities are threatening access even in high-income countries.
Swap Switzerland for your country.
Reuse the arguments.
Update the data.
Make it yours.👇
https://t.co/Vd0SMBn2ue
📢 As requested, key #resources are now available in ES🇪🇸, FR🇫🇷 & RU🇷🇺.
• Global Insulin Shortages & Stockouts (2023–2025)
• Sources of Insulin, Oral Medicines & Diabetes Devices for LMICs
🔗 https://t.co/EqdH0wNTP5
🔔Just 4 days to go!
Have you completed the @NCDPolicyLab#ImpactSurvey yet? It only takes a few minutes, but your input can make a lasting difference.
🔗https://t.co/pD6ADkkNF4
*anonymous & only be used for M&E purposes*
Make your voice count before it closes!
Thank you✨
Your voice matters for the #ImpactSurvey 2026!
Your insights are essential in shaping the future of the @NCDPolicyLab. It takes only few minutes, a small time commitment for a lasting impact 🚀
🔗 https://t.co/pD6ADkkNF4
🗓️: 20th February
Thank you for your support!✨
📸 A photograph by Antoine Martin, taken in the frame of #LIVINGWITH exhibition, is featured in @TheLancet Highlights 2025. A powerful recognition of his work and of photography’s role in telling #healthstories & the lived experience of people with #T1D
🔗https://t.co/mo9lSJgVWH
New year. Same challenge.
#Insulinshortages continue to affect countries worldwide across income levels and health systems.
📄 Documenting global insulin shortages and stockouts 2023–2025, full report available here 👉 https://t.co/TZiIXbx6Eh
**The information included in this document has been confirmed by United Nations (UN) agencies, manufacturers or suppliers and is subject to change and updates. This information is not in support of any agency, manufacturer, or supplier. It is for information purposes only.
🆕 Updated factsheet on Sources of insulin, oral medicines, and medical devices for diabetes for low- and middle-income countries
Practical guidance to support #access and #procurement.
📘 Read more: https://t.co/ii8nMeGfTT
✨Happy New Year 2026 from @NCDPolicyLab!
Advancing evidence-based policy, stronger systems, and equitable access to medicines and technologies.
Here is to a year of impact, partnership, and progress✨
A new @NCDPolicyLab report highlights that insulin shortages and stockouts are a global challenge, affecting countries across different regions and income groups.
You can learn more and download the full report here 👉 https://t.co/nhxbAGbvwx
During #UNGA, @NCDPolicyLab co-organised an event with @ncdalliance, @AtMIndex & @MedsPatentPool on improving access to NCD & mental health conditions treatments in LMICs.
🎥Find out more in this short video👇
https://t.co/hxGtcpCuYe
🔔 Insulin shortages and stockouts are a global problem across geographies and income groups
"Documenting global Insulin Shortages and Stockouts 2023–2025: Comprehensive overview using various data sources" is out!
Access to the report here👇https://t.co/TZiIXbxEtP
Last week, @NCDPolicyLab & @ncdalliance co-hosted a workshop to boost access to essential #NCD medicines, diagnostics & devices ✨
With key actors, this marks a major step forward for an idea born at the #HackccessHackathon! 🚀
The Lancet Diabetes & Endocrinology Commission on Type 1 Diabetes receives funding from @BreakthroughT1D and the @WorldDiabetesF, as well as overall coordination support from the @SwissDevCoop.
The Lancet T1D Commission was featured at #ISPAD2025 🌍
As @ispad_org once again provided a key platform new tech advances in #T1D management & ongoing challenges, the Commission contributes to bringing evidence and lived experience together to strengthen T1D care worldwide.